AMT

American Tower Corporation

NYQ · Real Estate

$167.26

-$3.52 (-2.06%)down -2.06%

24 September 2026 · delayed 15+ min

F

Quality score53.9 / 100

Cut-offs are the grader's own: 97+ for an A+, below 60 is an F.

American Tower Corporation earns a F on excellent profit margins (>20%) and strong ROE (>20%) but current ratio below 1.0 (liquidity concerns) and high debt-to-equity ratio (>2.0). Consider alternatives with better risk/reward profiles.

Model stance WEAK HOLD Suggested position 4.0% · $400.00 IQInvest estimate
Adjusted for Moderate investors, Medium-term investors 4.0% suggested allocation Change these

These change the suggested position size and the stance, not the category scores. Amount is in dollars.

IQ-AMT-20260924engine v1 · 7-category weighted scorecard

What it is worth, depending who you ask.

Today’s price against the year it has had and the targets analysts publish. Every marker is a reported figure, not a projection of ours.

52-week low

$160.06

Today's price

$167.26

Lowest analyst target

$188.00

52-week high

$197.41

Mean analyst target

$215.70

Highest analyst target

$260.00

AMT trades 19% of the way up its 52-week range, between $160.06 and $197.41. The mean analyst target of $215.70 is 29.0% above today's price.

Today’s price 52-week range Analyst price targets

Scored categories

Financial healthExcellent profit margins (>20%); Strong ROE (>20%); Current ratio below 1.0 (liquidity concerns); High debt-to-equity ratio (>2.0) 75.023%

Profit margin

31.08%

Net profit per unit of revenue

exceptionalWhat this means

Of every 100 units of revenue, this much survives as profit.

Margins this wide usually mean real pricing power or a moat.

Operating margin

45.41%

Before interest and tax

very highWhat this means

Profit from operations, before interest and tax, per 100 of revenue.

Typical of software and other businesses with little cost per extra sale.

Gross margin

73.77%

After the cost of goods only

highWhat this means

What is left of revenue after only the direct cost of the product.

Little marginal cost per sale, which is what lets software and pharma fund heavy R&D.

Return on equity

33.91%

Profit per unit of shareholder capital

very strongWhat this means

Profit generated per unit of shareholder capital.

Rare when sustained — check whether debt is flattering it, since borrowing shrinks the equity denominator.

Return on assets

4.89%

Profit per unit of assets

lowWhat this means

Profit generated per unit of everything the company owns.

Common in asset-heavy industries such as utilities, telecoms and airlines.

Debt to equity

438.72

Borrowings against equity

heavily gearedWhat this means

Borrowings measured against shareholder capital.

Debt magnifies both good years and bad, and raises the stakes when rates rise.

Current ratio

0.35

Short-term assets over short-term debts

tightWhat this means

Short-term assets against short-term obligations.

Below 1 the company owes more within a year than it holds — workable if customers pay up front, risky otherwise.

Quick ratio

0.30

As above, excluding inventory

tightWhat this means

Short-term assets excluding inventory, against short-term debts.

Very little liquid cover if receipts slow down.

Revenue growth

4.70%

Year on year

flatWhat this means

Change in revenue against the same period last year.

Growing slower than a typical economy — the business is mature or under pressure.

Earnings growth

138.50%

Year on year

very strongWhat this means

Change in earnings against the same period last year.

Check whether it is repeatable or a one-off — a single asset sale can flatter this badly.

Revenue

$5.49B

Trailing twelve months

Free cash flow

$2.92B

Cash left after capital spending

Operating cash flow

$5.77B

Cash from the business itself

Payout ratio

96.01%

Dividends as a share of earnings

above earningsWhat this means

The share of earnings paid out as dividends.

The dividend exceeds profit, so it is being funded from cash or debt — rarely sustainable.

Growth & momentumPoor 1-year return (-10.6%); Low Sharpe ratio (-0.20) 25.022%

Return, 1 month

-6.33%

Return, 3 months

-0.87%

Return, 6 months

1.96%

Return, year to date

-2.43%

Return, 1 year

-10.58%

Return, 3 years

4.76%

Sharpe ratio

-0.20

Return earned per unit of risk

negativeWhat this means

Return earned per unit of risk taken.

The risk taken has not been rewarded over this period.

Win rate

50.48%

Share of days that closed up

about evenWhat this means

The share of trading days that closed higher.

Close to a coin flip, which is the norm — returns come from the size of moves, not their count.

Average daily return

-0.01%

Best day

9.88%

Worst day

-7.66%

ValuationHigh P/B ratio (20.95) 45.018%

P/E ratio

22.98

Price against trailing earnings

moderateWhat this means

You pay 22.98 for every 1 unit of annual earnings.

Roughly the long-run market average band.

Forward P/E

23.86

Price against forecast earnings

moderateWhat this means

Price against next year's *forecast* earnings.

A conventional range.

PEG ratio

1.61

P/E adjusted for growth

fairWhat this means

P/E divided by the growth rate — it asks whether the price is justified by the growth.

Between 1 and 2 price and growth are roughly in step.

Price to book

20.95

Price against balance-sheet equity

well above bookWhat this means

Price against the accounting value of the company's net assets.

Normal for asset-light businesses, where the value sits in brands and software the balance sheet never records.

Price to sales

7.12

Price against revenue

highWhat this means

Price against revenue — usable when a company has no profit yet.

The price assumes today's revenue will convert into much more profit later.

EV / EBITDA

18.36

Whole-company value against cash earnings

highWhat this means

Whole-company value, debt included, against cash earnings.

Expensive even before interest, tax and depreciation are considered.

Enterprise value

$129.33B

Market value plus debt, minus cash — the price of the whole business

Shares outstanding

465,960,048

Shares the profit is split across

Dividend yield

4.19%

Annual dividend against price

meaningfulWhat this means

Annual dividend as a percentage of the share price.

A substantial part of the total return arrives as income.

TechnicalRSI in healthy range (30-70); MACD bearish (negative histogram) 55.015%

RSI (14)

36.6

Above 70 overbought, below 30 oversold

neutralWhat this means

A 0–100 momentum gauge over the last 14 sessions.

The middle band, where most trading days sit.

MACD

-0.54

Momentum against its own trend

MACD histogram

-0.95

Positive is bullish

ADX

10.8

Trend strength; above 25 is a real trend

no clear trendWhat this means

Trend strength, regardless of direction.

Below about 20 the price is ranging rather than trending.

20-day average

$174.98

50-day average

$172.94

200-day average

$175.39

Price vs 50-day

-3.28%

Price vs 200-day

-4.63%

Bollinger upper

$179.92

Bollinger lower

$170.04

Average true range

4.04

Typical daily trading range

Stochastic %K

5.4

RiskModerate beta (market-like risk) 40.012%

Volatility, annualised

26.97%

How far it swings in a year

normalWhat this means

How far the price typically swings over a year.

A typical range for an individual share.

Beta

0.90

Moves against the wider market

market-likeWhat this means

How much the price moves relative to the wider market.

Moves roughly in step with the index.

Maximum drawdown

-43.81%

Worst peak-to-trough fall

significantWhat this means

The worst peak-to-trough fall in the period measured.

A serious decline, though not unusual over a multi-year window.

Risk category

High

The engine's own banding

Analyst viewAnalyst consensus: Buy; Significant upside potential (29.0%) 100.010%

Consensus

Buy

What covering analysts rate it

Analysts covering

23

Mean price target

$215.70

Highest target

$260.00

Lowest target

$188.00

Implied upside

28.96%

Target against today's price

largeWhat this means

How far the mean analyst target sits above today's price.

A wide gap, which as often means the price has fallen as that the target is right.

Price against the S&P 500

180 trading days to 2026-09-24

AMT is 3.0% down over the window, against 10.9% up for the S&P 500 — behind by 13.9 points.
AMT -3.0%S&P 500 +10.9%
Show the numbers
Sampled across the window. Both columns are rebased to 100 on 2026-01-06, so they can be compared directly.
DateCloseAMT rebasedS&P 500 rebased
2026-01-06$172.43100.0100.0
2026-01-28$174.09101.0100.5
2026-02-19$181.23105.198.8
2026-03-12$176.40102.396.1
2026-04-02$170.3898.894.8
2026-04-24$176.52102.4103.2
2026-05-15$169.0298.0106.7
2026-06-08$187.31108.6106.6
2026-06-30$163.5794.9108.0
2026-07-22$166.0696.3108.0
2026-08-12$170.4398.8111.6
2026-09-02$172.92100.3110.4

How the score was built

Each category is scored 0–100, then multiplied by its weight. The seven contributions sum to the quality score.
CategoryScoreWeightContribution
Financial health75.023%17.2
Growth & momentum25.022%5.5
Valuation45.018%8.1
Technical55.015%8.2
Risk40.012%4.8
Analyst view100.010%10.0
ESG50.00%0.0
Quality score100%53.9

ESG is scored but carries no weight in this grade. Add ?esg=1 to the address to include it — the engine then redistributes weight across the other six, so the whole scorecard changes, not just one row.

Argue with the model

Every other grader hands you a number. This one hands you the model.

Move a slider, press Recalculate, and the grade is rebuilt from the same category scores. Nothing is hidden: the scores are the engine's, only the weighting is yours.

What each model believes. Pick one above, or set your own sliders below.
ModelThe emphasis
IQInvest defaultThe engine's own weighting: financial health 23% and performance 22% lead, valuation 18%, then technicals, risk and analysts.
Value investorPrice against worth dominates: valuation 40%, financial health 25%. Chart signals count for almost nothing.
Growth investorMomentum first: performance 40% and technicals 20%. Whether the price is fair today gets just 5%.
Sleep at nightStability over everything: risk 35% and financial health 30% together outweigh all other categories combined.
ChartistThe tape over the fundamentals: technicals 45% and performance 25%. Valuation is nearly ignored.
18%
23%
22%
12%
15%
10%
0%

These are IQInvest's own weights, totalling 100%.

Your grade

F

53.9 / 100

Identical to the IQInvest grade.

All 66 metricsOne flat sortable table, for when you want everything at once.
Metric Category Value Source
Shares outstandingValuation465,960,048Yahoo Finance
Price to salesValuation7.12Yahoo Finance
Price to bookValuation20.95Yahoo Finance
PEG ratioValuation1.61Yahoo Finance
P/E ratioValuation22.98Yahoo Finance
Forward P/EValuation23.86Yahoo Finance
EV / EBITDAValuation18.36Yahoo Finance
Enterprise valueValuation$129.33BYahoo Finance
Dividend yieldValuation4.19%Yahoo Finance
Stochastic %KTechnical5.4Yahoo Finance
RSI (14)Technical36.6Yahoo Finance
Price vs 50-dayTechnical-3.28%Yahoo Finance
Price vs 200-dayTechnical-4.63%Yahoo Finance
MACD histogramTechnical-0.95Yahoo Finance
MACDTechnical-0.54Yahoo Finance
Bollinger upperTechnical$179.92Yahoo Finance
Bollinger lowerTechnical$170.04Yahoo Finance
Average true rangeTechnical4.04Yahoo Finance
ADXTechnical10.8Yahoo Finance
50-day averageTechnical$172.94Yahoo Finance
200-day averageTechnical$175.39Yahoo Finance
20-day averageTechnical$174.98Yahoo Finance
Volatility, annualisedRisk26.97%Yahoo Finance
Risk categoryRiskHighYahoo Finance
Maximum drawdownRisk-43.81%Yahoo Finance
BetaRisk0.90Yahoo Finance
VolumeMarket data2,623,602Yahoo Finance
Previous closeMarket data$170.78Yahoo Finance
OpenMarket data$170.78Yahoo Finance
EmployeesMarket data4,866Yahoo Finance
Day lowMarket data$166.54Yahoo Finance
Day highMarket data$171.09Yahoo Finance
Average volumeMarket data2,823,887Yahoo Finance
52-week lowMarket data$160.06Yahoo Finance
52-week highMarket data$197.41Yahoo Finance
Worst dayGrowth & momentum-7.66%Yahoo Finance
Win rateGrowth & momentum50.48%Yahoo Finance
Sharpe ratioGrowth & momentum-0.20Yahoo Finance
Return, year to dateGrowth & momentum-2.43%Yahoo Finance
Return, 6 monthsGrowth & momentum1.96%Yahoo Finance
Return, 3 yearsGrowth & momentum4.76%Yahoo Finance
Return, 3 monthsGrowth & momentum-0.87%Yahoo Finance
Return, 1 yearGrowth & momentum-10.58%Yahoo Finance
Return, 1 monthGrowth & momentum-6.33%Yahoo Finance
Best dayGrowth & momentum9.88%Yahoo Finance
Average daily returnGrowth & momentum-0.01%Yahoo Finance
Revenue growthFinancial health4.70%Yahoo Finance
RevenueFinancial health$5.49BYahoo Finance
Return on equityFinancial health33.91%Yahoo Finance
Return on assetsFinancial health4.89%Yahoo Finance
Quick ratioFinancial health0.30Yahoo Finance
Profit marginFinancial health31.08%Yahoo Finance
Payout ratioFinancial health96.01%Yahoo Finance
Operating marginFinancial health45.41%Yahoo Finance
Operating cash flowFinancial health$5.77BYahoo Finance
Gross marginFinancial health73.77%Yahoo Finance
Free cash flowFinancial health$2.92BYahoo Finance
Earnings growthFinancial health138.50%Yahoo Finance
Debt to equityFinancial health438.72Yahoo Finance
Current ratioFinancial health0.35Yahoo Finance
Mean price targetAnalyst view$215.70Yahoo Finance
Lowest targetAnalyst view$188.00Yahoo Finance
Implied upsideAnalyst view28.96%Yahoo Finance
Highest targetAnalyst view$260.00Yahoo Finance
ConsensusAnalyst viewBuyYahoo Finance
Analysts coveringAnalyst view23Yahoo Finance
Add to portfolio Compare Peers Set a price target

Yahoo Finance via yfinance · delayed 15 minutes or more